Sanofi Gets CDSCO Panel Nod to Update Prescribing Information for Xenpozyme

New Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has recommended approval for updating the Prescribing Information of Xenpozyme (Olipudase alfa Powder for…

Continue ReadingSanofi Gets CDSCO Panel Nod to Update Prescribing Information for Xenpozyme

DCC Flags State-Level Gaps, Calls for Nationwide Uniform Enforcement of Drug Quality Standards

New Delhi: Aiming to tighten the nationwide oversight of drug quality, the Drugs Consultative Committee (DCC) has urged the Centre to address the growing non-uniformity in state-level implementation of medicine…

Continue ReadingDCC Flags State-Level Gaps, Calls for Nationwide Uniform Enforcement of Drug Quality Standards

No Monopoly Over Drug Names Derived from INNs: Bombay HC Rejects Aristo’s Injunction Bid Over Aceclo Trademark

New Delhi: The Bombay High Court has dismissed Aristo Pharmaceutical Private Limited's interim application seeking to restrain Healing Pharma India from using the trademarks ACECLOHEAL, ACECLOHEAL MR, and similar marks.…

Continue ReadingNo Monopoly Over Drug Names Derived from INNs: Bombay HC Rejects Aristo’s Injunction Bid Over Aceclo Trademark

Patient dies of cardiac arrest during DSE Test: Max Hospital Dehradun directed Rs 10 lakh compensation

Dehradun: Holding Dehradun-based Max Super Speciality Hospital and its cardiologist liable for deficiency in service and medical negligence, the State Consumer Disputes Redressal Commission has directed the hospital to pay Rs 10…

Continue ReadingPatient dies of cardiac arrest during DSE Test: Max Hospital Dehradun directed Rs 10 lakh compensation